Get the Stockscreener App
35.32
2.14%
0.74
After Hours:
35.32
Collegium Pharmaceutical Inc stock is traded at $35.32, with a volume of 390.48K.
It is up +2.14% in the last 24 hours and up +9.32% over the past month.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
See More
Previous Close:
$34.58
Open:
$34.76
24h Volume:
390.48K
Relative Volume:
0.79
Market Cap:
$1.14B
Revenue:
$780.57M
Net Income/Loss:
$62.87M
P/E Ratio:
20.57
EPS:
1.7171
Net Cash Flow:
$327.58M
1W Performance:
+7.65%
1M Performance:
+9.32%
6M Performance:
-1.48%
1Y Performance:
+27.14%
1-Day Range:
$34.33
$35.50
1-Week Range:
$32.40
$35.50
52-Week Range:
$26.72
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
35.32 | 1.12B | 780.57M | 62.87M | 327.58M | 1.7171 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
MSN Money - MSN
Is Collegium Pharmaceutical (COLL) Offering A Valuation Opportunity After Recent Share Price Weakness - Sahm
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Collegium Pharmaceutical Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to Decline - Yahoo Finance
Collegium Pharmaceutical (COLL) to Release Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) hits fresh high: Is there still room to run? - MSN
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - MarketBeat
Collegium to buy ADHD medicine Azstarys for up to $785M - MSN
Equities Analysts Offer Predictions for COLL Q2 Earnings - MarketBeat
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewswire
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $44 - Moomoo
Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN
Collegium (COLL) Stock: Worth Buying? (Edges Up) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Collegium Pharmaceutical stock (US19459E1029): Is its opioid pain management focus strong enough to - AD HOC NEWS
Collegium Pharmaceutical Targets 825 Million Dollars in 2026 Revenue - HarianBasis.co
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 64% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Collegium Pharmaceutical Inc (COLL) Stock Down 5.4% -- Now Under - GuruFocus
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 4.6%Here's What Happened - MarketBeat
Truist reiterates Buy on Collegium Pharmaceutical stock By Investing.com - Investing.com Canada
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56 - Moomoo
CapEx per share of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView — Track All Markets
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference - MarketBeat
Collegium (COLL) Stock: Investor Confidence (-1.99%) 2026-04-15Gap Down Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Massachusetts Financial Services Co. MA Increases Stock Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Aug Technicals: Does Collegium Pharmaceutical Inc offer margin of safetyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B - Moomoo
How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift - Yahoo Finance
Assessing Collegium Pharmaceutical (COLL) Valuation After Mixed Recent Share Price Performance - Sahm
Chipmakers Recap: What is the target price for Collegium Pharmaceutical Inc stockGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Sectors Review: Does Collegium Pharmaceutical Inc offer margin of safetyBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily
Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - TradingView — Track All Markets
Collegium to Participate in Upcoming Investor Conferences - Bitget
Collegium Pharmaceutical, Inc. (COLL) stock price, news, quote and history - Yahoo Finance UK
Collegium Pharmaceutical, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Filing Data (April 2, 2026) - Minichart
How Prospective US Tariffs on Branded Drug Imports Will Impact Collegium Pharmaceutical (COLL) Investors - Sahm
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo Finance UK
Inflation Data: What are analysts price targets for Collegium Pharmaceutical Inc2026 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):